Generated by GPT-5-mini| Sohn Conference Foundation | |
|---|---|
| Name | Sohn Conference Foundation |
| Formation | 2006 |
| Headquarters | New York City |
| Type | Nonprofit organization |
| Focus | Charitable fundraising, investment research |
Sohn Conference Foundation The Sohn Conference Foundation is a nonprofit based in New York City that raises funds for pediatric cancer research by hosting investment forums and philanthropy programs. It convenes investors, asset managers, hedge fund managers, private equity figures, and foundations to feature stock-picking presentations and awards, partnering with academic centers, hospitals, and research institutes. The foundation’s events attract participation from Wall Street firms, family offices, sovereign wealth funds, and media organizations.
Founded in 2006 by a group of finance professionals and philanthropists, the organization emerged amid networks connecting investors in Manhattan, Greenwich Village, and the Financial District. Early supporters included principals from firms such as Goldman Sachs, Morgan Stanley, Citigroup, JPMorgan Chase, and Lehman Brothers alumni. The inaugural gatherings drew figures from hedge fund firms like Bridgewater Associates, Soros Fund Management, Renaissance Technologies, and Tiger Management. Over time, partnerships formed with research hospitals including Memorial Sloan Kettering Cancer Center, St. Jude Children’s Research Hospital, Dana-Farber Cancer Institute, and Children’s Hospital of Philadelphia. The conference model paralleled investor meetings such as Berkshire Hathaway annual shareholders meeting and Salomon Brothers era symposiums while adapting ideas from philanthropic events like the Robin Hood Foundation galas and charity auctions hosted by Christie’s and Sotheby’s.
The foundation’s stated mission aligns capital markets expertise with biomedical research funding, channeling proceeds toward pediatric oncology through collaborations with institutions such as Harvard Medical School, Columbia University Irving Medical Center, Weill Cornell Medicine, Yale School of Medicine, and Johns Hopkins University. Key activities include organizing investor conferences similar in format to panels seen at World Economic Forum meetings and speaker series resembling those at Cato Institute or Brookings Institution forums. It administers award programs in the tradition of the MacArthur Fellows Program and the Rhodes Scholarship, while coordinating with donor-advised funds at Fidelity Charitable, Schwab Charitable, and Vanguard Charitable. The foundation also produces educational materials for alumni networks at institutions like Princeton University, Harvard University, Stanford University, University of Pennsylvania, and Columbia University.
Its flagship event, the Sohn Investment Research Conference, showcases stock-picking presentations by portfolio managers drawn from firms such as Citadel LLC, Point72 Asset Management, Two Sigma Investments, DE Shaw & Co., and Millennium Management. The conference format resembles pitch sessions common to Sequoia Capital partner reviews and venture capital demo days at Y Combinator, but with public-market investment theses presented to audiences including representatives from BlackRock, State Street Corporation, Invesco, and T. Rowe Price. Media coverage mirrors reporting by The Wall Street Journal, Financial Times, Bloomberg L.P., CNBC, and Reuters. The event awards a winner recognized by panels that have included analysts from Morningstar, FactSet Research Systems, S&P Global, and Moody’s Investors Service. Regional and satellite conferences have been held in cities linked to finance hubs such as London, Hong Kong, Singapore, San Francisco, Boston, and Chicago.
Funds raised support grants to pediatric oncology programs at hospitals and research centers including Children’s National Hospital, Seattle Children’s Hospital, Boston Children’s Hospital, and the University of California, San Francisco Medical Center. Grantmaking follows models used by organizations like the Gates Foundation and Howard Hughes Medical Institute, with scientific review panels featuring investigators from institutions such as National Institutes of Health, National Cancer Institute, Broad Institute, and Salk Institute for Biological Studies. The foundation’s philanthropic activities include endowments, seed grants, translational research awards, and support for clinical trials coordinated with networks such as Children’s Oncology Group and consortia involving European Organisation for Research and Treatment of Cancer collaborators. Corporate partners have included Pfizer, Novartis, Roche, Bristol-Myers Squibb, and Merck & Co..
The organization’s board and advisory committees have historically featured executives and directors from Kleiner Perkins, Andreessen Horowitz, Blackstone Group, KKR & Co. Inc., and Apollo Global Management. Legal and compliance support has been provided by law firms in the style of Skadden, Arps, Slate, Meagher & Flom, Sullivan & Cromwell, and Simpson Thacher & Bartlett. Audit and accounting practices mirror standards of firms such as PwC, Deloitte, Ernst & Young, and KPMG. The foundation coordinates with nonprofit regulatory bodies and philanthropic intermediaries including Council on Foundations and Charity Navigator frameworks.
Speakers and awardees have included prominent investors, clinicians, and researchers affiliated with Warren Buffett-style capital allocators, Nobel laureates connected to Harvard, MIT, and Stanford, and clinicians from leading hospitals. Past presenters have been portfolio managers and analysts associated with Paul Tudor Jones, Michael Burry, Jim Simons, Ray Dalio, and Bill Ackman-type figures, while scientific awardees have included researchers with ties to CRISPR pioneers at University of California, Berkeley and Broad Institute affiliates. Celebrity supporters and presenters have included actors and philanthropists associated with causes similar to work by Angelina Jolie, Michael J. Fox, Bill Gates, and Oprah Winfrey.
The foundation has been credited with channeling substantial private capital into pediatric cancer research and shaping philanthropic models linking finance and medicine, similar in influence to collaborations seen between Rockefeller Foundation initiatives and academic medical centers. Coverage and commentary have appeared in outlets such as New York Times, The Economist, Forbes, and Barron’s. Critics and commentators have compared its model to activist investor campaigns led by figures from Elliott Management and philanthropic critiques of finance-led charity echoed in discussions involving Occupy Wall Street and reports by ProPublica. Supporters point to funded trials, translational breakthroughs, and collaborations with agencies like Food and Drug Administration and European Medicines Agency as measures of success.
Category:Non-profit organizations based in New York City Category:Medical charities Category:Philanthropic organizations